Work

Phase I pharmacokinetic (PK) and pharmacodynamic (PD) evaluation of a small molecule inhibitor of Poly ADP-Ribose Polymerase (PARP), KU-0059436 (Ku) in patients (p) with advanced tumours

Year: 2006

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2006.24.18_suppl.3022

Authors: P. C. Fong, J. Spicer, S. Reade, A. Reid, L. Vidal, J. H. Schellens, A. Tutt, P. A. Harris, S. Kaye, J. S. De Bono

Institutions: Institute of Cancer Research, The Netherlands Cancer Institute, Royal Marsden Hospital

Language: English

Topic: PARP inhibition in cancer therapy

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2241745863

Cites:

Cited by: 35

Related to: 10